Genetic determinants of variability in warfarin response after the dose-titration phase.

Iwuchukwu OF, Ramirez AH, Shi Y, Bowton EA, Kawai VK, Schildcrout JS, Roden DM, Denny JC, Stein CM
Pharmacogenet Genomics. 2016 26 (11): 510-516

PMID: 27632229 · PMCID: PMC5300764 · DOI:10.1097/FPC.0000000000000244

MeSH Terms (19)

Adult African Americans Aged Aged, 80 and over Anticoagulants Calcium-Binding Proteins Carbon-Carbon Ligases Cytochrome P-450 CYP2C9 Cytochrome P450 Family 4 Epoxide Hydrolases European Continental Ancestry Group Female Humans International Normalized Ratio Male Middle Aged Pharmacogenomic Variants Vitamin K Epoxide Reductases Warfarin

Connections (2)

This publication is referenced by other Labnodes entities: